World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
40
Citations
8055
World Ranking
5491
National Ranking
75

Best Publications

  • Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

    Alexandre Prehn Zavascki;Alexandre Prehn Zavascki;Luciano Zubaran Goldani;Jian Li;Roger L. Nation

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

    Alexandre P Zavascki;Cecília G Carvalhaes;Renata C Picão;Ana C Gales

  • Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

    Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

  • Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

    Alexandre P. Zavascki;Luciano Z. Goldani;Guoying Cao;Silvana V. Superti

  • Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

    Alexandre P Zavascki;Roger L Nation

  • Combination therapy for carbapenem-resistant Gram-negative bacteria

    Unknown

  • Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.

    Unknown

  • The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections

    Unknown

  • The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic

    Unknown

  • Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

    Unknown

  • Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.

    Unknown

  • Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil

    Unknown

  • Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study

    Unknown

  • Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.

    Unknown

  • Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity.

    Roger L. Nation;Maria Helena da Silva Pitombeira Rigatto;Diego Rodrigues Falci;Alexandre Prehn Zavascki

  • Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study

    Unknown

  • Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India

    Juliana Coutinho Campos;Maria José Félix da Silva;Paulo Roberto Nascimento dos Santos;Elaine Menezes Barros

  • Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections

    Unknown

  • Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis

    Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: